Morisco F - Search Results

1

Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels: suggestions for diagnostic procedures and monitoring.

Morisco F, Pagliaro L, Caporaso N, Bianco E, Sagliocca L, Fargion S, Smedile A, Salvagnini M, Mele A; University of Naples Federico II, italy. Morisco F, et al. Dig Liver Dis. 2008 Jul;40(7):585-98. doi: 10.1016/j.dld.2008.02.003. Epub 2008 Apr 18. Dig Liver Dis. 2008. PMID: 18395501

2

Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis.

Caporaso N, Romano M, Marmo R, de Sio I, Morisco F, Minerva A, Coltorti M. Caporaso N, et al. Among authors: morisco f. J Hepatol. 1991 May;12(3):367-71. doi: 10.1016/0168-8278(91)90841-x. J Hepatol. 1991. PMID: 1658121

3

Familial clustering of hepatitis C virus infection and chronic liver disease.

Caporaso N, Morisco F, Romano M, Zembrino A, Coltorti M. Caporaso N, et al. Among authors: morisco f. Ital J Gastroenterol. 1990 Oct;22(5):281-2. Ital J Gastroenterol. 1990. PMID: 1966878

4

Prevalence of hepatitis C virus infection in the household contacts of patients with HCV-related chronic liver disease.

Coltorti M, Caporaso N, Morisco F, Suozzo R, Romano M, D'Antonio M. Coltorti M, et al. Among authors: morisco f. Infection. 1994 May-Jun;22(3):183-6. doi: 10.1007/BF01716699. Infection. 1994. PMID: 7523308

5

Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects.

Coltorti M, Romano M, Persico M, Morisco F, Tuccillo C, Caporaso N. Coltorti M, et al. Among authors: morisco f. Infection. 1995 Jan-Feb;23(1):33-6. doi: 10.1007/BF01710055. Infection. 1995. PMID: 7538100

6

Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.

Carella C, Amato G, Biondi B, Rotondi M, Morisco F, Tuccillo C, Chiuchiolo N, Signoriello G, Caporaso N, Lombardi G. Carella C, et al. Among authors: morisco f. Horm Res. 1995;44(3):110-4. doi: 10.1159/000184606. Horm Res. 1995. PMID: 7590640 Clinical Trial.

7

Basal core-IgM antibodies to hepatitis C virus are not predictive of successful alpha-interferon therapy.

Caporaso N, Tuccillo C, Morisco F. Caporaso N, et al. Among authors: morisco f. J Hepatol. 1995 Mar;22(3):377. doi: 10.1016/0168-8278(95)80293-2. J Hepatol. 1995. PMID: 7608491 No abstract available.

8

IgM anti-HCV core in HCV-RNA positive subjects with and without chronic liver disease.

Caporaso N, Morisco F, Romano M, Persico M, de Sio I, Tuccillo C. Caporaso N, et al. Among authors: morisco f. Ital J Gastroenterol. 1994 Sep;26(7):347-8. Ital J Gastroenterol. 1994. PMID: 7812028 No abstract available.

9

HCV infection and hepatocellular carcinoma in cirrhotics: what is the linkage?

Coltorti M, Caporaso N, Persico M, de Sio I, Marmo R, Morisco F, Tuccillo C, Romano M. Coltorti M, et al. Among authors: morisco f. Dig Dis Sci. 1994 Jul;39(7):1596-7. doi: 10.1007/BF02088075. Dig Dis Sci. 1994. PMID: 8026278 No abstract available.

10

Recombinant human interferon alpha-2a therapy for chronic hepatitis C with or without cirrhosis: comparison of 3 or 6 MU for 1 year.

Caporaso N, Suozzo R, Morisco F, D'Antonio M, Romano M, Coltorti M. Caporaso N, et al. Among authors: morisco f. Ital J Gastroenterol. 1993 Nov-Dec;25(9):482-6. Ital J Gastroenterol. 1993. PMID: 8123895 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters